Methods of treating patients having hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension

Details for Australian Patent Application No. 2010206032 (hide)

Owner Ikaria, Inc.

Inventors Baldassarre, James S.; Rosskamp, Ralf

Agent Mallesons

Pub. Number AU-B-2010206032

Parent 2009202685

Filing date 29 July 2010

Wipo publication date 2 September 2010

Acceptance publication date 8 December 2011

International Classifications

A61K 33/00 (2006.01) Medicinal preparations containing inorganic active ingredients

A61B 5/0205 (2006.01) Measuring for diagnostic purposes - Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition

A61K 9/72 (2006.01) Medicinal preparations characterised by special physical form - for smoking or inhaling

A61K 31/21 (2006.01) - Esters, e.g. nitroglycerine, selenocyanates

A61M 21/00 (2006.01) Other devices or methods to cause a change in the state of consciousness

Event Publications

19 August 2010 Complete Application Filed

2 September 2010 Application Open to Public Inspection

  Published as AU-B-2010206032

18 August 2011 Alteration of Name

  The name of the applicant has been altered to Ikaria, Inc.

8 December 2011 Application Accepted

  Published as AU-B-2010206032

16 February 2012 Alteration of Name

  The name of the applicant has been altered to INO Therapeutics LLC

5 April 2012 Standard Patent Sealed

12 April 2012 Licence Registered

  INO Therapeutics LLC ( Ikaria Australia Pty Ltd )

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010206033-Compounds, methods and pharmaceutical compositions for inhibiting PARP

2010206031-Oxadiazole derivatives as DGAT inhibitors